Can Fite Biopharma Ltd ADR Cash Flow Reinvestment Rate
Latest as of June 2023:
0.00x
Can Fite Biopharma Ltd ADR cash flow reinvestment rate. Can Fite Biopharma Ltd ADR (CANF) has a Cash Flow Reinvestment Rate of 0.00x as of June 2023, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $95.00K. Explore Can Fite Biopharma Ltd ADR (CANF) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$95.00K
USD
Capital Expenditures
$0.00
USD
Can Fite Biopharma Ltd ADR Cash Flow Reinvestment Rate by Year (None–None)
Can Fite Biopharma Ltd ADR cash flow reinvestment rate by year from None to None. Year-by-year capital reinvestment analysis for Can Fite Biopharma Ltd ADR. For the full cash flow conversion analysis, see Can Fite Biopharma Ltd ADR (CANF) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow